H. Stracke et al., A BENFOTIAMINE-VITAMIN-B COMBINATION IN TREATMENT OF DIABETIC POLYNEUROPATHY, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 104(4), 1996, pp. 311-316
In a double-blind, randomized, controlled study, the effectiveness of
treatment with a combination of Benfotiamine (an Allithiamine, a lipid
-soluble derivative of vitamin B1 with high bioavailability) plus vita
min B6/B12 on objective parameters of neuropathy was studied over a pe
riod of 12 weeks on 24 diabetic patients with diabetic polyneuropathy.
The results showed a significant improvement (p = 0.006) of nerve con
duction velocity in the peroneal nerve and a statistical trend toward
improvement of the vibration perception threshold. Long-term observati
on of 9 patients with verum over a period of 9 months support the resu
lts. Therapy-specific adverse effects were not seen. The results of th
is double-blind investigation, of the long-term observation and of the
reports in the literature support the contention that the neurotropic
benfotiamine-vitamin B combination represents a starting point in the
treatment of diabetic polyneuropathy.